BEIJING: About 90 per cent of Sinovac Biotech employees and their families have taken an experimental coronavirus vaccine developed by the Chinese ...
Sinovac, whose CoronaVac is in Phase 3 clinical trials and has been included in the emergency scheme, offered the candidate vaccine to approximately 2,000 to 3,000 employees and their families on a voluntary basis, CEO Yin Weidong told Reuters.“As a vaccine developer and manufacturer, a new outbreak could directly impact our vaccine production,” Yin said on the sidelines of an international trade fair in Beijing, explaining why his company was included in the emergency program.
Data gathered from the program could offer evidence of the vaccine’s safety, but such data, which is not part of the registered clinical trial protocols, will not be used as main materials that regulators review in judging whether to approve the vaccine for commercial use, Yin said. He said those who chose to be inoculated, including his wife and parents, had been informed of the potential side effects prior to taking the shot, and that its vaccine completing only early and mid-stage trials.Yin, who also took the shot, said doctors asked about their health conditions before the vaccination, and the occurrence rate of adverse reaction among those vaccinated has been “very low”.
Side effects after taking CoronaVac include fatigue, fever and pain, with mostly mild symptoms, according to results of a mid-stage trial sponsored by Sinovac, involving 600 participants and published last month ahead of peer review. No vaccine has passed final, large-scale trials to prove it is effective and safe enough to protect people against the virus that has led to over 870,000 deaths globally.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China's CNBG, Sinovac find more countries to test coronavirus vaccinesBEIJING (REUTERS) - China National Biotec Group (CNBG) and Sinovac Biotech said on Saturday (Sept 5) that they have each found two more countries to run late-stage clinical tests of their coronavirus vaccine candidates, as China steps up its efforts in the global race.. Read more at straitstimes.com.
Read more »
China's CNBG, Sinovac find more countries to test COVID-19 vaccinesChina National Biotec Group (CNBG) and Sinovac Biotech Ltd said on Saturday four more countries have agreed to run late-stage human tests of their ...
Read more »
Japan says it will bear cost of coronavirus vaccines for populaceJapan's government said on Friday it would bear the cost of providing coronavirus vaccines to the populace, as it aims for a comprehensive inoculation against the pandemic. The government also said it planned to establish funds to compensate for possible side effects from the vaccines. The plans
Read more »
J&J seeking one-third of COVID-19 vaccine trial volunteers in hard-hit Latin AmericaJohnson & Johnson will seek 20,000 volunteers for late-stage human trials of its experimental coronavirus vaccine in hard-hit Latin America, ...
Read more »